Search
for
Sort by
Research 241–270 of 1000+
- Pulmonary manifestations of Birt-Hogg-Dubé syndrome
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer
- Hair loss at 20 associated with prostate cancer risk later in life
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study
- Cancer risk by the subtype of alopecia
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- The Black identity, hair product use, and breast cancer scale
- Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank
- Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer
- Dermatologic Adverse Events from Cancer Treatments
- Causal Relationship and Potential Common Pathogenic Mechanisms Between Alopecia Areata and Related Cancer
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Impact of Chemotherapeutic Drug on People living with Cancer
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- S1 OPIOID RECEPTOR AGONISTS AND SERUM PROSTATE SPECIFIC ANTIGENE LEVEL: IS THERE A ROLE FOR PROSTATE CANCER CONTROL AND CHEMOPREVENTION?
- S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER?
- Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- Male pattern baldness and risk of incident skin cancer in a cohort of men
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
- Imaging prostate cancer (PCa) with [<sup>99m</sup> Tc(CO)<sub>3</sub> ]finasteride dithiocarbamate
- Outcome and clinical–biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastases
- An Overview of Chemotherapy Side Effects on Patients with Prostate Cancer, Bladder Cancer, and Testicular Cancer at Haji Adam Malik General Hospital Medan from 2020-2022
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives